Xiaoyun Pan

932 total citations
41 papers, 671 citations indexed

About

Xiaoyun Pan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Xiaoyun Pan has authored 41 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Economics and Econometrics. Recurrent topics in Xiaoyun Pan's work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Xiaoyun Pan is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Xiaoyun Pan collaborates with scholars based in United States, Switzerland and Germany. Xiaoyun Pan's co-authors include Usha Sambamoorthi, Ami Vyas, Huamao Mark Lin, Shiwei Gong, Mohammad Jahanzeb, Si Jin, Weixia Zhang, Nan Chen, Bo Zhu and Wei Wang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Xiaoyun Pan

34 papers receiving 657 citations

Peers

Xiaoyun Pan
Shahnaz Khan United States
Jean‐François Baladi United States
G. Pugnet France
B.M.K. Donato United States
Angela Wu United States
Marie‐Eve Beauchamp Canada
David Macarios United States
Dattatraya Patil United States
Ravinder Dhawan United States
Tomasz Rakowski Poland
Shahnaz Khan United States
Xiaoyun Pan
Citations per year, relative to Xiaoyun Pan Xiaoyun Pan (= 1×) peers Shahnaz Khan

Countries citing papers authored by Xiaoyun Pan

Since Specialization
Citations

This map shows the geographic impact of Xiaoyun Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyun Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyun Pan more than expected).

Fields of papers citing papers by Xiaoyun Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyun Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyun Pan. The network helps show where Xiaoyun Pan may publish in the future.

Co-authorship network of co-authors of Xiaoyun Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyun Pan. A scholar is included among the top collaborators of Xiaoyun Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyun Pan. Xiaoyun Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pan, Xiaoyun, et al.. (2025). Development of a PSMA and EphA2 dual-receptor-activated fluorescent probe for wash-free prostate cancer cell imaging. Bioorganic & Medicinal Chemistry. 125. 118217–118217. 1 indexed citations
3.
4.
Singal, Amit G., Xiaozhou Fan, Zdravko P. Vassilev, et al.. (2023). Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States. Cancers. 15(23). 5532–5532. 8 indexed citations
5.
Jahanzeb, Mohammad, Huamao Mark Lin, Xiaoyun Pan, et al.. (2020). Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 22(1). 49–57. 47 indexed citations
6.
Pan, Xiaoyun, et al.. (2019). PCN308 REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON–SMALL CELL LUNG CANCER (NSCLC). Value in Health. 22. S115–S115. 1 indexed citations
7.
Zhang, Zhiguo, et al.. (2018). Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China. PLoS ONE. 13(3). e0193273–e0193273. 67 indexed citations
8.
Vyas, Ami, S. Suresh Madhavan, Usha Sambamoorthi, et al.. (2017). Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer. Journal of the National Comprehensive Cancer Network. 15(11). 1401–1409. 13 indexed citations
9.
Simeone, Jason C., et al.. (2016). Initiation of triple therapy maintenance treatment among patients with COPD in the US. International Journal of COPD. Volume 12. 73–83. 59 indexed citations
10.
Gong, Shiwei, Yingxiao Wang, Xiaoyun Pan, et al.. (2016). The availability and affordability of orphan drugs for rare diseases in China. Orphanet Journal of Rare Diseases. 11(1). 20–20. 53 indexed citations
11.
Yu, Yanni, et al.. (2016). Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis. Journal of Managed Care & Specialty Pharmacy. 22(4). 414–423. 33 indexed citations
12.
13.
Pan, Xiaoyun & Usha Sambamoorthi. (2015). Health care expenditures associated with depression in adults with cancer. The Journal of Community and Supportive Oncology. 13(7). 240–247. 36 indexed citations
14.
Raval, Amit D., Xiaoyun Pan, & Usha Sambamoorthi. (2014). Fda Cdx Category Medication Use During Pregnancy in the United States. Value in Health. 17(7). A519–A519. 1 indexed citations
15.
Alwhaibi, Monira, Xiaoyun Pan, & Usha Sambamoorthi. (2014). Triptan Use For Migraine Headache Among Adults With Cardiovascular Risk. Value in Health. 17(3). A57–A58.
16.
17.
Loftus, Edward V., et al.. (2011). Adalimumab real-world dosage pattern and predictors of weekly dosing: Patients with Crohn's disease in the United States. Journal of Crohn s and Colitis. 5(6). 550–554. 10 indexed citations
18.
Link, Brian K., John M. Brooks, Kara Wright, et al.. (2011). Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines. Leukemia & lymphoma. 52(6). 994–1002. 30 indexed citations
19.
Zhu, Bo, Nan Chen, Yan Lin, et al.. (2007). Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. Nephrology Dialysis Transplantation. 22(7). 1933–1942. 93 indexed citations
20.
Liu, Yifei, et al.. (2007). Osteoporosis risk screening for women in a community pharmacy. Journal of the American Pharmacists Association. 47(4). 521–526. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shahnaz Khan Breakdown of academic impact, for papers by Jean‐François Baladi Breakdown of academic impact, for papers by G. Pugnet Breakdown of academic impact, for papers by B.M.K. Donato Breakdown of academic impact, for papers by Angela Wu Breakdown of academic impact, for papers by Marie‐Eve Beauchamp Breakdown of academic impact, for papers by David Macarios Breakdown of academic impact, for papers by Dattatraya Patil Breakdown of academic impact, for papers by Ravinder Dhawan Breakdown of academic impact, for papers by Tomasz Rakowski
Rankless by CCL
2026